Posted on April 26th, 2012, 3:59 pm
Seeking Alpha This will be driven by geographic expansion in new international markets as we broaden our EU sales focus beyond cardiac and vascular surgery. We have received positive feedback on the usage of PerClot in the EU for neurosurgery and prostate surgery ... |